|
Volumn 90, Issue 1, 2011, Pages 117-118
|
H1N1 in allogeneic stem cell recipients: Courses of infection and influence of vaccination on graft-versus-host-disease (GVHD)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOLOGICAL ADJUVANT;
IMMUNOSUPPRESSIVE AGENT;
INFLUENZA VACCINE;
OSELTAMIVIR;
2009 H1N1 INFLUENZA;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
ALLOIMMUNITY;
ARTIFICIAL VENTILATION;
CHRONIC GRAFT VERSUS HOST DISEASE;
DISEASE EXACERBATION;
FATALITY;
FLU LIKE SYNDROME;
GRAFT RECIPIENT;
HOSPITALIZATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFLUENZA VACCINATION;
LETTER;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
REMISSION;
SINGLE DRUG DOSE;
SYMPTOM;
THROAT CULTURE;
DISEASE PROGRESSION;
GRAFT VS HOST DISEASE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOCOMPROMISED HOST;
INCIDENCE;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
RISK FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
VACCINATION;
|
EID: 78651270426
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: 10.1007/s00277-010-0971-8 Document Type: Letter |
Times cited : (12)
|
References (4)
|